(Hypertension. 2000;35:685.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Johannes-Müller-Institut für Physiologie (K.W., K.D., A.U., P.B.P., H.M.S.) and Institut für Pathologie (H.G.), Humboldt-Universität (Charité), Berlin, Germany.
Correspondence to Klaus Wilfert, MD, Department of Physiology, Humboldt University Berlin, Charité, Tucholskystrasse 2, 10117 Berlin, Germany. E-mail klaus.wilfert{at}charite.de
| Abstract |
|---|
|
|
|---|
Key Words: rabbits cholesterol vasoconstriction cardiac output total peripheral resistance
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
-hydroxybutyrate-dehydrogenase (
-HBDH).
Animal Preparation and Experimental Protocol
Rabbits were anesthetized with urethane (1.5 g/kg bw,
IV) and placed on a thermostat table (Zimmerman, Leipzig,
Germany). Catheters for pressure measurements were positioned in
the left ventricle, in the abdominal aorta, and in the vena cava.
Additional catheters were implanted in both femoral veins for infusion
of Ang II and injection of the indicator solution for determination of
cardiac output. Pressure amplifiers provided the
ventricular, arterial, and central venous
pressure and the differentiated left ventricular pressure
signal (LV dP/dt). Heart rate was obtained from the ECG, and
end-diastolic pressure was obtained from the left
ventricular pressure signal using the ECG as a trigger
signal.12 The maximum of the LV dP/dt signal (LV
dP/dtmax) and its ratio to the instantaneous
pressure (LV dP/dtmax/P) were used as markers for
myocardial contractility. Cardiac output was measured
by the indocyanine dye dilution method, a modification of the technique
described by Angell-James et al.13 A stabilization period
of 30 to 45 minutes was allowed before hemodynamic
measurements were performed in anesthetized and spontaneously
breathing rabbits. An initial baseline period of 5 minutes was followed
by an intravenous infusion of 0.4 µg ·
kg-1 · min-1 Ang
II. This dose was selected on the basis of both the
literature11 14 and pilot experiments in which we applied
doses in the range of 0.4 to 4.0 µg ·
kg-1 · min-1. The
dose of 0.4 µg · kg-1 ·
min-1 is within the range of the upper plateau
of the dose-response curve for blood pressure.14 Ang II
infusion was stopped after 15 minutes, and the recording was
continued for a final recovery period of 5 minutes. Cardiac output,
stroke volume, and total peripheral resistance were
determined in the initial baseline period and during the 3rd and 14th
minute of Ang II infusion. Baroreceptorheart rate reflex sensitivity
was assessed by linear regressions between arterial
pressure and heart period with the pressure increase and
decrease that occurred in response to the onset of Ang II infusion (0.4
µg · kg-1 ·
min-1) and its termination, respectively. These
sections of the recordings lasted for
3 minutes. Only linear
regressions with regression coefficients >0.85 were considered.
Eight hours after the hemodynamic measurements, both ventricles, the abdominal and thoracic sections of the aorta, the carotids, and the quadriceps muscle were taken for lipid chemical and histological examinations. The myocardium was inspected for necrotic lesions, scar tissue, and fibrosis. In addition, conduit vessels (aorta, carotids, and coronary arteries) and arterioles in the perivascular tissue of the aorta and carotids as well as within the myocardium were examined morphometrically with special attention to atherosclerosis.
Statistics
Data are mean±SEM. Comparisons between both dietary groups were
performed by unpaired t tests. Time courses were tested by
2-way ANOVA (time versus dietary treatment). Post hoc t
tests were performed to test individual differences, if the 2-way ANOVA
revealed statistical significance. Statistical significance was assumed
at P<0.05.
| Results |
|---|
|
|
|---|
-HBDH increased
temporarily during the high-cholesterol feeding period and
returned to normal at the end of the 6-week postcholesterol
period.
|
Tissue cholesterol content in the aorta was increased 4-fold by high-cholesterol alimentation, whereas cholesterol content in the myocardium and skeletal muscle did not rise significantly (Figure 1B). The pathohistological effects of a high-cholesterol diet on the vascular system are shown in Figure 2. At week 18, a marked atherosclerosis was observed in the conduit vessels but not in the resistance vessels. The extent of the myocardial lesions (granulation tissue and scars) was only 1.3% on average. None of the animals included in this study had myocardial tissue damage of >4%. Fresh myocardial necroses were not observed.
|
Hemodynamic Effects of Ang II
To minimize potential influences of excessively high serum lipid
and cholesterol levels on the hemodynamic
measurements, these recordings were performed at week 18, ie, 6
weeks after the high-cholesterol diet was terminated.
Baseline hemodynamic conditions at week 18 are provided
in Table 1. Significant differences were
not found between the 2 groups. No hemodynamic signs of
cardiac dysfunction were observed. Infusion of Ang II initially caused
an increase in arterial blood pressure of
20 mm Hg
in both groups. Despite the continuous infusion of Ang II, blood
pressure gradually declined in both groups and reached baseline levels
at the end of the infusion (minute 14) in the control group but not in
the high cholesterol group (Figure 3, top). Ang II infusion also decreased
heart rate in control rabbits (Figure 3, middle), which was
probably caused by activation of the arterial baroreceptor
reflex. In contrast, rabbits that had been maintained on a
high-cholesterol diet for 12 weeks did not show a reduced
heart rate to the same extent, indicating a reduced baroreceptorheart
rate reflex sensitivity. Left ventricular
end-diastolic pressure increased significantly during Ang
II infusion in both groups (Figure 3, bottom). The
contractility index LV dP/dtmax/P
similarly decreased in both groups (Figure 3, bottom). Ang
IIinduced changes in cardiac output, mean arterial
pressure, and total peripheral resistance at the 3rd and
14th minute of Ang II infusion are shown in Figure 4. A significantly diminished cardiac
output was found for the group that was fed cholesterol.
The increase in total peripheral resistance associated with
the Ang II infusion was more pronounced in rabbits that received the
atherogenic diet. At the end of Ang II infusion, this difference in the
overall vascular response to Ang II reached statistical
significance.
|
|
|
Arterial Baroreflex Sensitivity
The slope relating pulse interval to arterial blood
pressure was less steep in the rabbits that received the
high-cholesterol diet (Figure 5). This can be taken as a sign for a
blunted baroreceptorheart rate reflex sensitivity. This
interpretation is further substantiated by the heart rate time course
depicted in Figure 3. Although mean arterial
pressure increased almost to a similar amount in both groups, or even
slightly more in the high-cholesterol group at the end of
the infusion, bradycardia was stronger in the control animals.
|
| Discussion |
|---|
|
|
|---|
High-cholesterol feeding markedly increased total serum lipids and vascular cholesterol content (Figure 1) and thus caused atherosclerosis (Figure 2). Studies in isolated vessels from atherosclerotic rabbits are equivocal with regard to the vasoconstrictor response to Ang II. Dam and coworkers9 found a reduced response in aortic rings and no difference in iliac arteries. In contrast, Yang et al3 found an enhanced response to Ang II in aortic rings. In vivo studies are also difficult to reconcile. For example, Hof and Hof11 describe an enhanced pressure effect of systemically administered Ang II, while Carroll et al10 found that both the systemic pressure response and the renal vasoconstrictor response to intrarenal Ang II infusions were similar in control and atherosclerotic rabbits. This diversity within the literature prompted us to test whether the overall vascular responsiveness to Ang II is enhanced in atherosclerosis and whether an impairment of cardiovascular control mechanisms adds to this hyperresponsiveness. According to this hypothesis, the vasoconstrictor response to Ang II would be less effectively antagonized by the baroreflex and, consequently, cause a stronger increase in total peripheral resistance in atherosclerosis. This interpretation was, indeed, substantiated by the present study. First, total peripheral resistance increased more in response to systemically administered Ang II in atherosclerotic rabbits (Figure 4). Second, baroreflex sensitivity to the heart was markedly reduced in cholesterol-fed animals (Figure 5). Accordingly, the bradycardic response to the Ang IIinduced hypertension was blunted in cholesterol-fed animals, which would be expected if the baroreflexes were impaired (Figure 3). Third, resistance vessels were excluded from the atherosclerotic process, suggesting a contribution of extravascular mechanisms to the increased vascular response to Ang II.
Recent in vitro experiments on the effects of Ang II in atherosclerotic
vessels support our findings obtained in the whole animal: Yang and
colleagues demonstrated a 5-fold increase in Ang II receptor
expression,3 and Song et al have observed an increased
angiotensin-converting enzyme activity in atherosclerotic
vessels.2 The latter group also found that Ang II type 1
receptor density increased in the medial lesion. Thus, a basis exists
for assuming that the vasoconstrictor response of conduit vessels to
Ang II is enhanced. In spite of the pronounced
atherosclerosis and enhanced vascular response to Ang
II, baseline blood pressure was not higher in
cholesterol-fed rabbits (Table 1). Similar results
were found by Zuckerman et al15 after 11 weeks of
high-cholesterol feeding in rabbits. However, after a
longer dietary cholesterol challenge, hypertension may
occur. Angell-James16 found a significant increase in
baseline blood pressure after a high-cholesterol diet of
67 weeks. We recorded arterial blood pressure 6 weeks
after cholesterol feeding was terminated. Thereby, abnormal
serum enzyme activities or excessively high serum levels of
cholesterol and serum lipids were avoided. Thus, we cannot
rule out that arterial blood pressure may have been higher
during the 12 weeks of high-cholesterol feeding and
returned to normotensive values within the postcholesterol
period. Furthermore, the kidney, a key organ in the control of
arterial blood pressure, may have effectively prevented
hypertension in the present study. At least from a functional point
of view, renal vascular resistance is not affected by a
high-cholesterol diet nor is the renal vascular response to
Ang II changed.10 When observed morphologically, the renal
microvasculature seems to be protected, perhaps by an increase in
cholesterol esterase.17
A reduced afferent baroreceptor activity in atherosclerotic animals was first described by Angell-James.16 With an elegant approach, she performed nerve recordings from the aortic nerve while locally altering aortic arch pressure. Compared with controls, lower frequencies in the impulse discharges of afferent baroreceptor fibers in atherosclerotic rabbits were found, indicating that the afferent arch of the baroreflex is on fault in atherosclerosis. Like other investigators,18 19 20 21 we also found a reduced baroreceptorheart rate reflex in atherosclerosis. Because primarily the afferent portion of the reflex is impaired in atherosclerosis,16 one can expect that the sensitivity of both the baroreceptor-sympathetic nerve activity reflex and the baroreceptorheart rate reflex is reduced in atherosclerosis. Indeed, it has been demonstrated that baroreflex control of sympathetic renal nerve activity is depressed in conscious WHHL rabbits.18 Thus, the Ang IIinduced increase in arterial blood pressure may elicit a smaller reduction in sympathetic nerve activity directed to the resistance vessels and, hence, may add to the enhanced vascular responsiveness to Ang II in vivo. There are several levels at which atherosclerosis can blunt the baroreflex. Li and associates have shown that endogenous oxygen-derived radicals, which can be produced by atherosclerotic vessels, attenuate the carotid nerve response to pressure changes.22 Furthermore, platelet activation in carotid sinuses, a common site of atherosclerotic lesions, which may facilitate platelet aggregation, markedly attenuates reflex-mediated changes in renal sympathetic nerve activity.23 Altered vessel wall structure as a result of hypercholesterolemia24 may also account for an attenuated baroreflex, because increased aortic and carotid vessel stiffness can change baroreflex characteristics.25 Yet, it seems unlikely that an attenuation of the arterial baroreflex is due to heart failure.26 27 Although interspersed scar tissue was detected in the ventricles, none of the hemodynamic characteristics showed any signs of a failing heart (Table 1, Figure 3). In addition, a reduced end-organ response to autonomic nervous discharge does not seem likely to account for the attenuated baroreflex sensitivity seen in this model of atherosclerosis. As mentioned above, isolated atherosclerotic vessels appear to be supersensitive to adrenergic transmitters.6 7 8
In summary, this study provides data of Ang II effects on total peripheral resistance in atherosclerotic animals. Ang II increased total peripheral resistance by a greater degree in rabbits fed cholesterol. Furthermore, baroreceptor reflex sensitivity was markedly reduced. Thus, it is reasonable to assume that the baroreflex blunted the vascular response to Ang II to a lesser degree in atherosclerotic animals. In vivo, an attenuated sensitivity of the baroreceptor reflex may, therefore, add to the enhanced overall vascular responsiveness to Ang II associated with atherosclerosis.
| Acknowledgments |
|---|
Received June 2, 1999; first decision June 28, 1999; accepted September 29, 1999.
| References |
|---|
|
|
|---|
2. Song K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim S, Miyazaki M. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed cynomolgus monkeys. Atherosclerosis. 1998;138:171182.[Medline] [Order article via Infotrieve]
3.
Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta
P, Mehta JL. Increased angiotensin II type 1 receptor
expression in hypercholesterolemic
atherosclerosis in rabbits. Arterioscler Thromb
Vasc Biol. 1998;18:14331439.
4.
Wilson PW, Hoeg JM, DAgostino RB, Silbershatz H,
Belanger AM, Poehlmann H, OLeary D, Wolf PA. Cumulative effects of
high cholesterol levels, high blood pressure, and cigarette
smoking on carotid stenosis. N Engl J Med. 1997;337:516522.
5.
Nazzaro P, Manzari M, Merlo M, Triggiani R, Scarano A,
Ciancio L, Pirrelli A. Distinct and combined vascular effects of ACE
blockade and HMG-CoA reductase inhibition in hypertensive subjects.
Hypertension. 1999;33:719725.
6.
Rosendorff C, Hoffman JI, Verrier ED, Rouleau J,
Boerboom LE. Cholesterol potentiates the coronary
artery response to norepinephrine in anesthetized
and conscious dogs. Circ Res. 1981;48:320329.
7. Heric E, Tackett RL. Altered vascular reactivity in the rabbit during hypercholesterolemia. Pharmacology. 1985;31:7281.[Medline] [Order article via Infotrieve]
8. Tesfamariam B, Weisbrod RM, Cohen RA. Augmented adrenergic contractions of carotid arteries from cholesterol-fed rabbits due to endothelial cell dysfunction. J Cardiovasc Pharmacol. 1989;13:820825.[Medline] [Order article via Infotrieve]
9. Dam JP, Vleeming W, Riezebos J, Post MJ, Porsius AJ, Wemer J. Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites. J Cardiovasc Pharmacol. 1997;3:118123.
10.
Carroll JF, Mizelle HL, Cockrell K, Reckelhoff JF,
Clower BR, Granger JP. Cholesterol feeding does not alter
renal hemodynamic response to acetylcholine and
angiotensin II in rabbits. Am J Physiol. 1997;272:R940R947.
11. Hof RP, Hof A. Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits. Br J Pharmacol. 1988;95:10751080.[Medline] [Order article via Infotrieve]
12. Stauss HM, Redlich T, Zhu YC, Adamiak D, Mott A, Kregel KC, Unger T. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J Cardiovasc Risk. 1994;1:255262.[Medline] [Order article via Infotrieve]
13. Angell-James JE, Clarke JA, de Burgh Daly M, Taton A. Carotid chemoreceptor function and structure in the atherosclerotic rabbit: respiratory and cardiovascular responses to hyperoxia, hypoxia and hypercapnia. Cardiovasc Res. 1989;23:541553.[Medline] [Order article via Infotrieve]
14.
Dickinson CJ, Yu R. The progressive pressor response to
angiotensin in the rabbit. J Physiol. 1967;190:9199.
15.
Zuckerman BD, Weisman HF, Yin FC. Arterial
hemodynamics in a rabbit model of
atherosclerosis. Am J Physiol. 1989;257:H891H897.
16.
Angell-James JE. Arterial baroreceptor
activity in rabbits with experimental atherosclerosis.
Circ Res. 1974;34:2739.
17. Kamanna VS, Vora S, Roh D, Kirschenbaum MA. Comparative studies on acid cholesterol esterase in renal blood vessels and aorta of control and hypercholesterolemic rabbits. Atherosclerosis. 1992;94:2733.[Medline] [Order article via Infotrieve]
18. Morita H, Nishida Y, Motochigawa H, Watanabe Y, Hosomi H. Depressed baroreflex control of renal nerve activity in conscious WHHL rabbits. Cardiovasc Res. 1988;22:679685.[Medline] [Order article via Infotrieve]
19. Vlachakis ND, Mendlowitz M, DGuia D, DGusman D. Diminished baroreceptor sensitivity in elderly hypertensives: possible role of atherosclerosis. Atherosclerosis. 1976;24:243249.[Medline] [Order article via Infotrieve]
20. Katsuda S, Hosomi H, Shiomi M, Watanabe Y. Impaired baroreflex control of arterial pressure in WHHL rabbits. J Vet Med Sci. 1992;54:983987.[Medline] [Order article via Infotrieve]
21. Hosomi H, Katsuda S, Watanabe Y. Effect of atherosclerosis on the responsiveness of the rapidly acting arterial pressure control system in WHHL rabbits. Cardiovasc Res. 1986;20:195200.[Medline] [Order article via Infotrieve]
22.
Li Z, Mao HZ, Abboud FM, Chapleau MW. Oxygen-derived
free radicals contribute to baroreceptor dysfunction in atherosclerotic
rabbits. Circ Res. 1996;79:802811.
23. Mao HZ, Li Z, Chapleau MW. Platelet activation in carotid sinuses triggers reflex sympathoinhibition and hypotension. Hypertension. 1996;27(pt 2):584590.
24.
Farrar DJ, Bond MG, Riley WA, Sawyer JK. Anatomic
correlates of aortic pulse wave velocity and carotid artery elasticity
during atherosclerosis progression and regression in
monkeys. Circulation. 1991;83:17541763.
25.
Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE,
Abboud FM. Structural versus functional modulation of the
arterial baroreflex. Hypertension. 1995;26:341347.
26. Willenbrock R, Stauss H, Scheuermann M, Osterziel KJ, Unger T, Dietz R. Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity. Am J Physiol. 1997;273(pt 2):H2580H2585.
27.
Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor
reflex in dogs with experimental heart failure. Circ Res. 1991;68:12941301.
This article has been cited by other articles:
![]() |
H. M. Stauss and P. B. Persson Role of Nitric Oxide in Buffering Short-Term Blood Pressure Fluctuations Physiology, October 1, 2000; 15(5): 229 - 233. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |